Clinical characteristics and biopsy specimen features in African- American and white men without prostate cancer

Journal of the National Cancer Institute

Volumn 90, Issue 10, 1998, Pages 756-760

  Eastham, James A ^a,d   May, Robert A ^b   Whatley, Terence ^c   Crow, Arden ^b   Venable, Dennis D ^a   Sartor, Oliver ^b  

^a OVERTON BROOKS VA MEDICAL CENTER   (United States)

^b LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

^c Overton Brooks Vet Aff Med Center

^d School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CAUCASIAN; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; NEGRO; PROSTATE BIOPSY; PROSTATE CANCER; RACE DIFFERENCE;

EID: 0032550707     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/90.10.756     Document Type: Article

References (26)

1. Parker SL, Tone T, Bolden S, Wingo PA. Cancer statistics, 1997 [published erratum appears in CA Cancer J Clin 1997;47:68]. CA Cancer J Clin 1997;47:5-27.
2. Boring CC, Squires TS, Health CW Jr. Cancer statistics for African Americans [published erratum appears in CA Cancer J Clin 1992;42:125]. CA Cancer J Clin 1992;42:7-17.
3. Morton RA Jr. Racial differences in adenocarcinoma of the prostate in North American men. Urology 1994;44:637-45.
4. Moul JW, Sesterhenn IA, Connelly RR, Douglas T, Srivastava S, Mostofi FK, et al. Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men. JAMA 1995;274:1277-81.
5. Vijayakumar S, Karrison J, Weichselbaun RR, Chan S, Quadri SF, Awan AM. Racial differences in prostate-specific antigen levels in patients with local-regional prostate cancer. Cancer Epidemiol Biomarkers Prev 1992;1: 541-5.
6. Morgan TO, Jacobsen SJ, McCarthy WF, Jacobson DJ, McLeod DG, Moul JW. Age-specific reference ranges for prostate-specific antigen in black men. N Engl J Med 1996;335:304-10.
7. DeAntoni EP, Crawford ED, Oesterling JE, Ross CA, Berger ER, McLeod DG, et al. Age- and race-specific reference ranges for prostate-specific antigen from a large community-based study. Urology 1996;48: 234-9.
8. Henderson RJ, Eastham JA, Culkin DJ, Kattan MW, Whatley T, Mata J, et al. Prostate-specific antigen (PSA) and PSA density: racial differences in men without prostate cancer. J Natl Cancer Inst 1997;89: 134-8.
9. Oesterling JE, Jacobsen SJ, Chute CG, Guess HA, Girman CJ, Panser LA, et al. Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges. JAMA 1993; 270:860-4.
10. Benson MC, Whang IS, Olsson CA, McMahon DJ, Cooner WH. The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen. J Urol 1992;147: 817-21.
11. Nadler RB, Humphrey PA, Smith DS, Catalona WJ, Ratliff TL. Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate specific antigen levels. J Urol 1995;154:407-13.
12. Brawn PN, Speights VO, Kuhl D, Riggs M, Spiekerman M, McCord RG, et al. Prostate-specific antigen levels from completely sectioned, chemically benign, whole prostates. Cancer 1991;68:1592-9.
13. Brawer MK, Rennels MA, Nagle RB, Schifman R, Gaines JA. Serum prostate-specific antigen and prostate pathology in men having simple prostatectomy. Am J Clin Pathol 1989;92:760-4.
14. Rosin MP, Anwar WA, Ward AJ. Inflammation, chromosomal instability, and cancer: the schistosomiasis model. Cancer Res 1994;54(7 Suppl): 1929s-1933s.
15. Kawai K, Kawamata H, Kemeyama S, Rademaker A, Oyasu R. Persistence of carcinogen-altered cell population in rat urothelium which can be promoted to tumors by chronic inflammatory status. Cancer Res 1994;54: 2630-2.
16. Ellis L, Nyborg H. Racial/ethnic variations in male testosterone levels: a probable contributor to group differences in health. Steroids 1992;57: 72-5.
17. Henderson BE, Bernstein L, Ross RK, Depue RH, Judd HL. The early in utero oestrogen and testosterone environment of blacks and whites: potential effects on male offspring. Br J Cancer 1988;57:216-8.
18. Ahluwalia B, Jackson MA, Jones GW, Williams AO, Rao MS, Rajguru S. Blood hormone profiles in prostate cancer patients in high-risk and low-risk populations. Cancer 1981;48:2267-73.
19. Ross R, Bernstein L, Judd H, Hanisch R, Pike M, Henderson B. Serum testosterone levels in healthy young black and white men. J Natl Cancer Inst 1986;76:45-8.
20. Caskey CT, Pizzuti A, Fu YH, Fenwick RG Jr, Nelson DL. Triplet repeat mutations in human disease. Science 1992;256:784-9.
21. Edwards A, Hammond HA, Jin L, Caskey CT, Chakraborty R. Genetic variation at five trimeric and tetrameric tandem repeat loci in four human population groups. Genomics 1992;12:241-53.
22. Irvine RA, Yu MC, Ross RK, Coetzee GA. The CAG and GGC microsatellites of the androgen receptor gene are in linkage disequilibrium in men with prostate cancer. Cancer Res 1995;55:1937-40.
23. Sartor O, Zheng Q, Eastham JA. Androgen receptor gene exon one CAG repeats vary in a racially defined manner in men with a normal serum prostate-specific antigen [abstract]. Proc ASCO 1997;16:313a.
24. Chamberlain NL, Driver ED, Miesfield RL. The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res 1994;22:3181-6.
25. Giovannucci E, Stampfer MJ, Krithivas K, Brown M, Dahl D, Brufsky A, el al. The CAG repeat within the androgen receptor gene and its relationship to prostate cancer [published erratum appears in Proc Natl Acad Sci U S A 1997;94:8272]. Proc Natl Acad Sci U S A 1997;94:3320-3.
26. Ingles SA, Ross RK, Yu MC, Irvine RA, La Pera G, Haile RW, et al. Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor. J Natl Cancer Inst 1997;89: 166-70.